Colfax Corporation (CFX)
Stock Price Chart
Key Info
| Market Cap | 3.62B |
| Revenue (ttm) | 3.46B |
| Net Income (ttm) | -471.14M |
| Shares Out | 118.33M |
| EPS (ttm) | -3.45 |
| PE Ratio | n/a |
| Forward PE | 22.08 |
| Dividend | n/a |
| Dividend Yield | n/a |
Stock Quote
| Trading Day | Aug 4, 2020 |
| Last Price | $30.57 |
| Previous Close | $30.42 |
| Change ($) | 0.15 |
| Change (%) | 0.49% |
| Day's Open | 30.20 |
| Day's Range | 29.88 - 30.92 |
| Day's Volume | 1,325,615 |
| 52-Week Range | 12.23 - 39.30 |
More Stats
| Market Cap | 3.62B |
| Enterprise Value | 5.93B |
| Earnings Date (est) | Aug 6, 2020 |
| Ex-Dividend Date | n/a |
| Shares Outstanding | 118.33M |
| Float | 100.48M |
| EPS (basic) | -3.46 |
| EPS (diluted) | -3.45 |
| FCF / Share | 1.15 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Earnings Yield | n/a |
| FCF Yield | 3.75% |
| Payout Ratio | n/a |
| Shares Short | 18.31M |
| Short Ratio | 16.75 |
| Short % of Float | 19.80% |
| Beta | 1.85 |
| PE Ratio | n/a |
| Forward PE | 22.08 |
| P/FCF Ratio | 26.70 |
| PS Ratio | 1.05 |
| PB Ratio | 1.08 |
| Revenue | 3.46B |
| Operating Income | 214.50M |
| Net Income | -471.14M |
| Free Cash Flow | 135.49M |
| Net Cash | -2.31B |
| Net Cash / Share | -19.52 |
| Gross Margin | 40.74% |
| Operating Margin | 6.20% |
| Profit Margin | -13.60% |
| FCF Margin | 3.92% |
| ROA | 2.40% |
| ROE | 1.39% |
| ROIC | -5.50% |
Analyst Summary
Analyst Consensus: Buy
Financial Performance
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3,327 | 2,193 | 1,937 | 3,186 | 3,434 | 4,624 | 4,207 | 3,914 | 693 | 542 |
| Revenue Growth | 51.73% | 13.2% | -39.19% | -7.24% | -25.74% | 9.92% | 7.5% | 464.45% | 27.94% | - |
| Gross Profit | 1,401 | 729 | 672 | 992 | 1,072 | 1,479 | 1,306 | 1,152 | 240 | 191 |
| Operating Income | 170 | 152 | 88.67 | 237 | 266 | 410 | 406 | 140 | 25.91 | 34.37 |
| Net Income | -528 | 140 | 151 | 128 | 168 | 392 | 179 | -64.40 | 4.56 | 16.22 |
| Shares Outstanding | 118 | 117 | 123 | 123 | 124 | 124 | 102 | 93.98 | 43.60 | 43.40 |
| Earnings Per Share | -3.89 | 1.16 | 1.22 | 1.04 | 1.34 | 3.02 | 1.54 | -0.92 | 0.10 | 0.37 |
| EPS Growth | - | -4.92% | 17.31% | -22.39% | -55.63% | 96.1% | - | - | -72.97% | - |
| Operating Cash Flow | 131 | 226 | 219 | 247 | 304 | 386 | 362 | 174 | 57.15 | 61.97 |
| Capital Expenditures | -118 | -34.82 | -47.54 | -56.00 | -69.88 | -84.46 | -71.48 | -83.19 | -13.62 | -12.45 |
| Free Cash Flow | 13.33 | 192 | 171 | 191 | 234 | 301 | 291 | 90.83 | 43.53 | 49.51 |
| Cash & Equivalents | 110 | 77.15 | 412 | 209 | 197 | 305 | 311 | 482 | 75.11 | 60.54 |
| Total Debt | 2,448 | 1,197 | 1,061 | 1,292 | 1,418 | 1,537 | 1,487 | 1,728 | 112 | 82.50 |
| Net Cash / Debt | -2,339 | -1,120 | -649 | -1,083 | -1,220 | -1,231 | -1,176 | -1,246 | -36.41 | -21.96 |
| Assets | 7,387 | 6,616 | 6,710 | 6,338 | 6,733 | 7,212 | 6,601 | 6,148 | 1,089 | 1,022 |
| Liabilities | 3,897 | 3,139 | 2,982 | 3,245 | 3,476 | 3,859 | 3,860 | 3,992 | 899 | 806 |
| Book Value | 3,441 | 3,270 | 3,500 | 2,897 | 3,070 | 3,147 | 2,514 | 1,912 | 189 | 216 |
Company Profile
Company Details
| Full Name | Colfax Corporation |
| Country | United States |
| Employees | 15,000 |
| CEO | Matthew L. Trerotola |
Stock Information
| Ticker Symbol | CFX |
| Stock Exchange | New York Stock Exchange |
| Sector | Industrials |
| Industry | Specialty Industrial Machinery |
| Unique Identifier | NYSE: CFX |
| IPO Date | May 8, 2008 |
Description
Colfax Corporation operates as a diversified technology company worldwide. The company operates through two segments, Medical Technology and Fabrication Technology. The Medical Technology segment offers orthopedic solutions, including orthopedic devices and braces, reconstructive and surgical implants, footwear, bone growth stimulators, and software and services spanning the full continuum of patient care, as well as injury prevention, rehabilitation, pain management, and physical therapy under the Aircast, Chattanooga, CMF, Compex, DonJoy, ProCare, DJO Surgical, Dr. Comfort, Exos, and MotionMD brand names. Its products are used by orthopedic specialists, spine surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. This segment sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and direct and independent salespersons. The Fabrication Technology segment formulates, develops, manufactures, and supplies consumable products and equipment for use in cutting, joining, and automated welding of steels, aluminum, and other metals and metal alloys. It also provides welding consumables comprising electrodes, cored and solid wires, and fluxes using a range of specialty and other materials; and cutting consumables, such as electrodes, nozzles, and shields and tips under the ESAB brand name. This segment sells its products through independent distributors and direct sales to the infrastructure, wind power, marine, pipelines, mobile/off-highway equipment, oil, gas, and mining markets. Colfax Corporation was founded in 1860 and is headquartered in Annapolis Junction, Maryland.